Most obesity drugs do not improve quality of life or heart health, analysis indicates

3 months ago 10
Despite important value loss, astir obesity drugs specified arsenic Wegovy and Mounjaro bash not meaningfully amended prime of life, and fewer amusement cardiovascular benefits astatine 1 year, according to an investigation of the latest grounds published by The BMJ.
Read Entire Article